Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi PEA S&P 500 Screened UCITS ETF - Acc

PE500 · FR0013412285 · class Acc · EUR · domicile France
Equity · United States · Large cap · Sustainable / ESGSFDR art. 8
Index tracked: S&P 500 Scored & Screened+ Index (USD) NTR
TER
0.25%+ trans. 0.00%
Fund size
1 bn EUR
Tracking difference
−0.43%3-year avg
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Mixed (acc. and/or dist.)
Launch 25 Apr 2019 · costs from the KID as of 2 Sept 2026 · 65 securities held · 6 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
By subscribing to Amundi PEA S&P 500 Screened UCITS ETF - EUR, you are investing in a passively managed UCITS whose objective is to replicate as closely as possible the performance of the S&P 500 Scored and Screened+ Index (USD) NTR (the "Index") regardless of whether it experiences a positive or negative development. The maximum tracking error objective between the growth of the net asset value of the Fund and that of the Index is indicated in the Fund's prospectus. The Index, net dividends reinvested (dividends net of tax paid by the shares in the…

Performance since series start (in euro) — base 100

25 Apr 20198 Sept 2026 · dividends reinvested where declared by the issuer
202020212022202320242025202628083275
High 280 (12 Aug 2026) · low 83 (16 Mar 2020) · last 275. Past performance is not indicative of future results.

Returns in euro

1 year+22.8%
3 years+62.1%
5 years+81.6%
10 yearsseries too young
Since series start+174.6%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.77%15.74%17.22%
Max drawdown−7.91%−22.82%−22.82%
Sharpe1.480.880.62
Sortino2.191.270.88
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · PE500 · FR00134122851
RebalixPE500 · FR0013412285 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+3.72%+4.34%−0.62%
2024+31.71%+32.37%−0.66%
2023+21.53%+21.54%−0.01%
2022−12.95%−13.17%+0.22%
2021+38.24%+37.89%+0.35%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 65 securities · top-10 weight = 50.8%
Top holdingsWeight
ASML HOLDING NV9.0%
SIEMENS ENERGY AG7.0%
FERROVIAL SE MADRID5.6%
ELI LILLY & CO5.4%
SIEMENS AG-REG4.8%
MICROSOFT CORP4.3%
ALLIANZ SE-REG4.1%
AIRBUS SE PARIS3.9%
FRESENIUS SE & CO KGAA3.5%
ING GROEP NV3.3%

Listing venues

ESMA register (FIRDS) and official exchange lists
18M9 · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse Stuttgart, Tradegate Exchange
PE500 · Euronext Paris
+ 20 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.ch/pdfDocuments/kid-priips/FR0013412285/ENG/CHE
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0013412285/FRA/FRA/I
Prospectus · www.amundietf.ch/pdfDocuments/prospectus/FR0013412285/ENG/CHE
The live sheet, always up to date
rebalix.com/en/etf/FR0013412285
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · PE500 · FR00134122852